Target intelligence / Profile preview

Serotonin receptor type 3 (5-HT₃ receptor)

Target
5-HT₃ receptor
Molecular classification
Ligand-gated ion channel, Cys-loop receptor, Ion channel, Receptor
01

Overview

Serotonin receptor type 3 (5-HT₃ receptor) is a member of the Cys-loop superfamily of ligand-gated ion channels and is structurally and functionally distinct from other serotonin (5-HT) receptors, which are G protein-coupled receptors[1][5][6][3]. The 5-HT₃ receptor forms a pentameric structure that acts as a cation-selective channel permeable to sodium, potassium, and calcium. It plays a pivotal role in fast excitatory neurotransmission in both the central and peripheral nervous systems and is highly expressed in areas related to emesis, including the brainstem and gastrointestinal tract[1][3][6][9]. Activation of the 5-HT₃ receptor by serotonin results in rapid neuronal depolarization, leading to effects such as vomiting, nausea, and modulation of gut motility. Clinically, pharmacological antagonists of the 5-HT₃ receptor are widely used to treat and prevent nausea and vomiting, particularly in the context of chemotherapy, radiotherapy, and postoperative recovery[7][9]. The receptor is also being studied in relation to additional CNS and gastrointestinal disorders.

Other names
5-hydroxytryptamine receptor 35-HT3 receptor5-HT3RSerotonin-gated ion channel
02

Mechanism of action

Antagonism (blockade) of serotonin binding at the 5-HT₃ receptor; Inhibition of ligand-gated cation channel opening

03

Biological functions

Fast excitatory neurotransmissionSignal transductionRegulation of neurotransmitter releaseModulation of gut motility and secretion
04

Disease associations

Nausea and vomiting (including chemotherapy-induced and postoperative)Irritable bowel syndromeAnxietyEmesisGastrointestinal disorders
05

Safety considerations

Possible QT interval prolongation (especially with ondansetron)Risk of serotonin syndrome when combined with other serotonergic drugsHeadacheConstipationRare hypersensitivity reactions
06

Interacting drugs

Ondansetron

5 more in the full profile.

07

Biomarkers

5-HT₃ receptor expression levels (primarily in research settings)

Beyond the preview

Go deeper on Serotonin receptor type 3 (5-HT₃ receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin receptor type 3 (5-HT₃ receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call